Schizophrenia is a severe mental disorder affecting behavior, thought and emotions in the form of hallucinations, delusions and cognitive impairment. Dopamine system is implicated in the pathogenesis of schizophrenia through dopamine receptors expression in the brain. 
INTRODUCTION
Schizophrenia is a debilitating neuropsychiatric disorder with a lifetime incidence of approximately 1% worldwide that impairs mental and social functioning and often leads to the development of comorbid diseases (Philip et al., 2016). Individuals with schizophrenia may experience positive, negative and cognitive symptoms. Traditional positive symptoms alter the patient's sense of reality. It means things "added" or "new" to the personality. It includes hallucinations (presence of perceptual aberrations) that may be auditory, visual and tactile delusions and confused thoughts and speech (Young and Geyer, 2015) . Negative symptoms include decreased daily activities, socialization, flat affect and alogia (Foussias et al., 2014).
Dopamine (DA) is a catecholamine neurotransmitter that is a precursor to the synthesis of the neurotransmitters norepinephrine (NE) and epinephrine (Wang et al., 2014) involved in pleasure and reward through mesolimbic pathway (Ayano et al., 2016) and highly involved in cognition, working memory, and decision making through mesocortical pathway (Yadav et al., 2014) . Dopamine action is mediated by five subtypes of dopamine receptors, D1 family including (D1and D5 receptors) and D2 family including (D2, D3 and D4 receptors) which are members of the large G-protein coupled receptor (GPCRs) super family (Ayano, 2016).
They are encoded in humans by genes DRD1, DRD2, DRD3, DRD4 and DRD5 mediating the physiological functions of dopamine (Beaulieu et al., 2015). D1-family activate the Gs/olf family of G proteins stimulating cAMP production by Adenylyl Cyclase and are found exclusively postsynaptically on dopamine-receptive cells, while D2-family couple to the Gi/olf family of G proteins inhibiting Adenylyl Cyclase and are expressed both postsynaptically on dopamine target cells and presynaptically on dopaminergic neurons (Rondou et al., 2010). The "original dopamine hypothesis" states that hyperactive dopamine transmission results in schizophrenic symptoms (Madras BK, 2013). There is enhanced presynaptic DA in basal ganglia responsible for positive symptoms, while the negative and cognitive symptoms of schizophrenia can be attributed to a reduced dopaminergic tone in cortical areas (Kuepper et al. 2012).
The study of mRNA Expression of Dopamine Receptors ……..
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In human brain, D3R mRNA has been detected in nucleus accumbens where their concentration is particularly high in the ventral stratum responsible for psychotic symptoms playing a role in cognitive and emotional functions (Maramai et al., 2016). D3 antagonism was found to improve certain cognitive spheres by increasing acetylcholine release at the prefrontal cortex level disinhibiting the activity of dopamine neurons projecting to the nucleus accumbens or prefrontal cortex, or activating cAMP-response element-binding protein (CREB) signaling in the hippocampus which act as neuroprotective (Nakajima et al., 2013).
The aim of this work is to evaluate the role of mRNA expression of dopamine receptors D2 and D3 in the diagnosis of schizophrenia.
MATERIALS AND METHODS
This study was carried out at Medical Biochemistry and Psychiatry Departments, the patients were attendants of outpatient clinic and from inpatient department of Psychiatry at the first day of admission, Menoufia University Hospital during the period from May to November 2017. 50 subjects were enrolled in the study; they were 35 schizophrenic patients (15 males and 20 females) with mean age X ± SD was 34.57±8.89 and 15 age and gender matched healthy controls (8 males and 7 females) with mean age of 35.47±12.69. The study was approved by ethical committee of Faculty of Medicine, Menoufia University. A written informed consent was obtained from all subjects. Diagnosis of schizophrenia was based on the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, , that states that for the diagnosis of schizophrenia, the patient must have experienced at least 2 of the following symptoms: (Delusions, Hallucinations, Disorganized speech, Disorganized or catatonic behavior and Negative symptoms).
Two (or more) of the following must be present; (delusions, hallucinations, disorganized speech, catatonic behavior and negative symptoms) for at least 6 months, during which the patient must experience at least 1 month of active symptoms (or less if successfully treated), with social or occupational deterioration problems occurring over a significant amount of time. Schizoaffective disorder, depressive 
Samples collection:
Five milliliters (ml) of venous blood were taken from each subject and divided as follows: 3 ml were put in plain tube left to clot for 30 minutes at room temperature then subjected to centrifugation for 10 minutes at 4000 r.p.m. The serum obtained was separated and stored at -80°C until determination of serum HDL-c, serum TG cholesterol and serum LDL-c. 2 ml of blood were transferred into EDTA containing tube for determination of Dopamine receptor D2 and D3 genes mRNA expression by RT-qPCR.
Assay methods:
Serum total cholesterol and triglycerides and high-density lipoprotein cholesterol (HDL-c) . For the detection of Dopamine receptors DRD2 and DRD3 mRNA levels, the following primers were used: forward and reverse primers for human DRD2, 5'-AGACCATGAGCCGTAGGAAG-3' and 5'-GCAGCCAGCAGATGATGA-3', respectively; forward and reverse primers for human DRD3 5'-CAACCCTGATTTTGTCATCTACTCT-3'and 5'-CTTTGTTTCAGCACCACATAGATTC-3', respectively; forward and reverse primers for human β-Actin, 5'-GAGCGGGAAATCGTGCGTGACATT-3' and 5'-GAAGGTAGTTTCGTGGATGCC-3' respectively. PCR was conducted under the following conditions: Each reaction for each gene was performed in a final volume 20 µL, containing, 10 μl 2x QuantiTect SYBR Green PCR Master Mix, 3 μl Template cDNA, 1ul forward primer, 1ul reverse primer and 5 μl RNase-free water. The mix was incubated at 95 c for 15 minutes followed by 45 cycles: denaturation at 94°C for 15s, annealing at 58°C for 30s and extension at 72°C for 30s. Data analysis using Applied Biosystems 7500, software version 2.0.1. The relative quantitation (RQ) of gene expression performed using Comparative ΔΔCt method (Dorak, 2000). DRD2 and DRD3 mRNA levels were normalized to the mRNA level of housekeeping gene B actin. Melting curve was performed to confirm specificity of the amplification and absence of primer dimers. 
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Statistical analysis:
The data collected was tabulated and analyzed by SPSS (statistical package for the social science) software version 20. Chisquare test is used to study the association between two qualitative variables. Student's t test was used to assess the statistical significance of parametric data. Spearman's correlation was used for skewed distributed quantitative variables. Odds ratio (OR) describes the probability that people who are exposed to a certain factor disease compared to people who are not exposed to the factor. Values less than 0.05 were considered significant.
RESULTS
The results show that there is non-significant statistical difference between studied groups regarding age and gender while there is significant statistical difference between studied groups regarding cognitive symptoms, positive symptoms and negative symptoms (Table 1) .There was significant statistical increase in the mRNA expression of dopamine receptors D2 and D3 in the blood of group I compared to group II (Table 2 ).There was significant statistical decrease of HDL-c and increase of LDL-c in group I when compared to group II, while There is no significant statistical difference of Cholesterol and TAG when group I compared to group II (Table 3 ).There was no significant statistical difference between HDL in patients with suicidal attempts and those with no suicidal history in group I, while there was significant statistical decrease of LDL, Cholesterol and TAG in patients with suicidal attempts regarding those with no suicidal history in group I (Table 4 ).There was nonsignificant correlation between dopamine receptors D2 and D3 mRNA expression and age in both studied groups (Table 5 ).There was non-significant correlation between dopamine receptors D2 mRNA expression and lipid profile in both studied groups (Table  6 ).There was non-significant correlation between dopamine receptors D3 mRNA expression and HDL-c in both studied groups, while there is positive correlation between dopamine receptors D3 mRNA expression and LDL-c, Cholesterol and TAG in patient group (Table  7) .Multivariate logistic regression for risk of schizophrenia showed that the most common risk factor is DRD3 OR; 12.3 (0.01-11.4), followed by DRD2 OR; 5.8 (0.2-9.7) ( (PUFAs) the main material of membranes and play a role in myelination being essential constituents of all cell membranes and the myelin sheaths around the axons. They are vulnerable to damage by free radicals due to their double-bond structure (lipid peroxidation) which leads to damages of cell membrane fluidity and permeability, signal transduction by decreasing arachidonic acid concentration which is correlated with greater severity of negative symptom of schizophrenia (Peters et al., 2013). The current study showed that age and gender were matched between patients and control. There was no significant statistical difference (p > 0.05) between studied groups regarding age and gender. These results are in agreement with those reported by (2014) reported that patients had worse cognitive domains (verbal memory, speed of processing and working memory) than healthy controls and confirmed that cognitive deficits are present also in drugnaïve patients at an early stage of the illness. The present study showed that the patient group had significant statistical increase (p < 0.001) of mRNA expression of dopamine receptors D3 in the blood of schizophrenic patients compared to control group. These results agree with those reported by (Ahmadian  et al., 2014, Cui et al., 2015 and Asaad et al., 2018) . Cui et al., (2015) reported that the mRNA expression level of DRD3 in the blood of patients with schizophrenia was significantly greater than that of the controls. They reported that DRD3 is preferentially localized in limbic areas, having a role in emotions, motivation, and reward with higher levels of mRNA were expressed in the nucleus accumbens. This was observed in the brains of drug-free schizophrenic patients, but not in medicated patients at the time of death reflecting that the increased expression of DRD3 mRNA in T lymphocytes may reflect hyperdopaminergic neurotransmission in the brain. Our study revealed that patient group had significant statistical increase (p = 0.001) of mRNA expression of dopamine receptors D2 genes in the blood of schizophrenic patients when compared to control group this was in accordance with (Lai CY et al., 2016 and Liu et al., 2017). Lai et al., (2016) reported that the levels of lymphocyte DRD3 mRNA was reported to be elevated in both people with chronic schizophrenia and people with drug naïve schizophrenia. They also reported both mRNA expression and receptor binding of DRD2 were increased in lymphocytes from people with drug naïve schizophrenia. Striatal hyperdopaminergic state is a significant finding in schizophrenia through overexpression of striatal D2 receptors which is associated with impairments in working memory One et al., (2018) .
In contrast with our study, Kawano et al., (2011) and UrhanKucuk et al., (2011) reported that there were no statistically significant differences in the levels of these DRD3 receptor mRNAs in schizophrenic patients and controls. Furthermore, in other studies there was no significant differences in the DRD2 mRNA levels between the schizophrenic patients and controls, so DRD2 mRNA levels in the blood may be related to the severity of psychiatric (2016) reported that the levels of triglyceride were significantly higher in patients with schizophrenia than in healthy controls. They found that the patients did not receive antipsychotic treatment when TAG was measured, so the higher levels of serum triglyceride may be associated with the disease itself, and not only a result of medication. The present study showed that patient group with suicidal attempts history had significant statistical decrease (p < 0.001) of serum LDLc, cholesterol and TAG compared to patients without suicide history, while no difference between HDL-c of both groups. These results agree with those reported by Ainiyet B. et al., (2014). Lalovic et al., (2010) reported that -mortem study reported down regulation of lipid metabolism mortem genes in the frontal cortex of suicide completes. Mensi et al., (2016) matched our results regarding to total cholesterol and HDL-c but they reported no significant difference between LDL-c and TAG of both groups.
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There is a neurochemical connection between suicide and reduced levels of serum cholesterol as current hypotheses suggest a decreased serotonergic activity through altered affinity and function of serotonin receptors and transporters due to a decrease in cholesterol in the lipid rafts of synaptic membranes. Other mechanisms have been explained that increased impulsivity in suicidal individuals, including steroid modulation and brain-derived neurotrophic factor decrease, which could also be related to changes in lipid raft and reduction in the lipid viscosity of neuronal cell membranes Cantarelli et al., (2014). The current study reported that there is non-significant correlation between dopamine receptors D2 and D3 mRNA expression and age in both studied groups. These results agree with those reported by (Liu et al., 2013 and Asaad et al., 2018). Moreover, the current study reported that there was positive correlation between dopamine receptors D3 mRNA expression and LDL-c, Cholesterol and TAG in both groups. There is an evidence that high cholesterol levels may be important to human learning and memory. Elevated serum cholesterol is a risk factor for mild cognitive impairment and showed the level of the cholesterol precursors lanosterol and lathosterol during cholesterol synthesis are correlated with low memory performance Schreurs., (2010). Furthermore, the current study reported that DRD3 and DRD2 mRNA expression in blood can be considered as a risk factor for developing schizophrenia. DRD2 mRNA levels in peripheral blood of drug-naive schizophrenic patients were found to be over-expressed and the receptor binding of DRD2 was increased (Liu et al., 2013 and Lai et al., 2016). Research by the Psychiatric Genomic Consortium (PGC) supported the notion that the DRD2 gene coding for the D2 dopaminergic receptor is associated with risk for schizophrenia and its genetic variation has been linked with types of schizophrenia and its treatment Pergola et al., (2017). DRD3 was reported to have a possible clinical significance for being a rapid diagnostic marker for people who are suspicious of schizophrenia, according to (Ahmadian et al., 2014 and Cui et al., 2015). The current study revealed high sensitivity and specificity of D2 and D3 receptors in schizophrenic patients making them can be used as prognostic markers of schizophrenia. 
